Evogene Ltd [EVGN] stock prices are up 17.07% to $1.1 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EVGN shares have gain 5.26% over the last week, with a monthly amount glided 6.80%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Evogene Ltd [NASDAQ: EVGN] stock has seen the most recent analyst activity on October 08, 2021, when ROTH Capital initiated its Buy rating and assigned the stock a price target of $7. Previously, Aegis Capital started tracking the stock with Buy rating on July 29, 2021, and set its price target to $10. On December 01, 2020, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $9 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $26 on December 16, 2013.
The stock price of Evogene Ltd [EVGN] has been fluctuating between $0.93 and $2.42 over the past year. Currently, Wall Street analysts expect the stock to reach $3.5 within the next 12 months. Evogene Ltd [NASDAQ: EVGN] shares were valued at $1.1 at the most recent close of the market. An investor can expect a potential return of 218.18% based on the average EVGN price forecast.
Analyzing the EVGN fundamentals
The Evogene Ltd [NASDAQ:EVGN] reported sales of 5.25M for trailing twelve months, representing a drop of -82.63%. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -2.85%, Pretax Profit Margin comes in at -2.19%, and Net Profit Margin reading is -2.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is 4.39 and Total Capital is -1.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-3.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9869 points at the first support level, and at 0.8737 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1566, and for the 2nd resistance point, it is at 1.2131.
Ratios To Look Out For
It’s worth pointing out that Evogene Ltd [NASDAQ:EVGN]’s Current Ratio is 4.92. In addition, the Quick Ratio stands at 4.41 and the Cash Ratio stands at 0.55. Considering the valuation of this stock, the price to sales ratio is 1.83, the price to book ratio is 8.40.
